Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

51.06
Delayed Data
As of Jun 24
 -2.34 / -4.38%
Today’s Change
46.17
Today|||52-Week Range
60.34
-12.09%
Year-to-Date

Stock Price Forecast

The 32 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 63.67, with a high estimate of 75.98 and a low estimate of 44.97. The median estimate represents a +24.71% increase from the last price of 51.06.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.58
Sales
$4.3B
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.18%
 
 
 
 
 
 
Growthannually 18.77%
 
 
 
 
 
 

Sales

Growthquarterly 3.43%
 
 
 
 
 
 
Growthannually 10.99%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.